US imaging firms protest over proposed CTA cover
This article was originally published in Clinica
A proposal by the US Centers for Medicare and Medicaid Services (CMS) to impose tight Medicare coverage conditions on the ever-growing practice of computed tomographic angiography (CTA) has met with a wave of protest from cardiologists, radiologists and industry. The CMS is due to issue its final ruling in the next few days.
You may also be interested in...
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.